Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacogenomics of 5-fluorouracil in colorectal cancer: review and update
Pan Xie, Junluan Mo, Jinhong Liu, et al.
Cellular Oncology (2020) Vol. 43, Iss. 6, pp. 989-1001
Closed Access | Times Cited: 67

Showing 1-25 of 67 citing articles:

A Rodent Model of Human-Dose-Equivalent 5-Fluorouracil: Toxicity in the Liver, Kidneys, and Lungs
Mariana Conceição da Silva, Lilian Catarim Fabiano, Karile Cristina da Costa Salomão, et al.
Antioxidants (2023) Vol. 12, Iss. 5, pp. 1005-1005
Open Access | Times Cited: 27
Interaction of 5-Fluorouracil on the Surfaces of Pristine and Functionalized Ca12O12 Nanocages: An Intuition from DFT
Goodness J. Ogunwale, Hitler Louis, Tomsmith O. Unimuke, et al.
ACS Omega (2023) Vol. 8, Iss. 15, pp. 13551-13568
Open Access | Times Cited: 25
Energy Metabolism and Stemness and the Role of Lauric Acid in Reversing 5-Fluorouracil Resistance in Colorectal Cancer Cells
Rina Fujiwara‐Tani, Yi Luo, Ruiko Ogata, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 664-664
Open Access | Times Cited: 1
Molecular mechanisms associated with chemoresistance in esophageal cancer
Matheus Lohan-Codeço, Maria Luísa Barambo-Wagner, Luiz Eurico Nasciutti, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 2
Open Access | Times Cited: 35
Nanoparticles: Attractive tools to treat colorectal cancer
Nour K. Younis, Rami Roumieh, Emmanuel P. Bassil, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 1-13
Open Access | Times Cited: 35
Computational Identification of Druggable Bioactive Compounds from Catharanthus roseus and Avicennia marina against Colorectal Cancer by Targeting Thymidylate Synthase
Md Rashedul Islam, Md Abdul Awal, Ahmed Khames, et al.
Molecules (2022) Vol. 27, Iss. 7, pp. 2089-2089
Open Access | Times Cited: 29
Linking Metabolic Reprogramming, Plasticity and Tumor Progression
Oleg Shuvalov, Alexandra Daks, Olga Fedorova, et al.
Cancers (2021) Vol. 13, Iss. 4, pp. 762-762
Open Access | Times Cited: 35
PREVENTION OF DAMAGES OF THE GASTRIC AND DUODENAL MUCOSA DURING CHEMOTHERAPY
Yaroslavna Yakimenko, V. V. Kutukov, V. V. Antonyan, et al.
ASTRAKHAN MEDICAL JOURNAL (2023), pp. 97-105
Open Access | Times Cited: 13
Mechanisms of Pharmaceutical Therapy and Drug Resistance in Esophageal Cancer
Chengyi Mao, Xiaoxi Zeng, Chao Zhang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 29
Precision medicine-guided co-delivery of ASPN siRNA and oxaliplatin by nanoparticles to overcome chemoresistance of colorectal cancer
Chengzhi Huang, Yue Zhou, Qi‐Song Tong, et al.
Biomaterials (2022) Vol. 290, pp. 121827-121827
Closed Access | Times Cited: 22
Comparing in vitro cytotoxic drug sensitivity in colon and pancreatic cancer using 2D and 3D cell models: Contrasting viability and growth inhibition in clinically relevant dose and repeated drug cycles
Tia Tidwell, Gro Vatne Røsland, Karl Johan Tronstad, et al.
Cancer Medicine (2024) Vol. 13, Iss. 11
Open Access | Times Cited: 4
Synergistic Inhibition of Colorectal Cancer Growth by Qingjie Fuzheng Granule and 5-Fluorouracil through the Phosphatidylinositol 3-kinase/Protein Kinase B Pathway
Jinyan Zhao, Jie Liu, Shi-Lan Chen, et al.
World Journal of Traditional Chinese Medicine (2025)
Open Access
Integrating multi-cohort machine learning and clinical sample validation to explore peripheral blood mRNA diagnostic biomarkers for prostate cancer
Xing‐Yu Zhong, Yuxuan Yang, Hao‐Dong He, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
DCBLD2 Affects the Development of Colorectal Cancer via EMT and Angiogenesis and Modulates 5-FU Drug Resistance
Pan Xie, Fuqiang Yuan, Masha Huang, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 26
Erosive-ulcerative lesions of the mucous membrane of the stomach and duodenum during therapy with 5-fluorouracil
Ya. A. Yakimenko, V. V. Kutukov, V. V. Antonyan, et al.
Ural Medical Journal (2022) Vol. 21, Iss. 6, pp. 119-127
Open Access | Times Cited: 16
Pharmacogenomic-guided dosing of fluoropyrimidines beyond DPYD: time for a polygenic algorithm?
Anthi Maslarinou, Vangelis G. Manolopoulos, Georgia Ragia
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 10
Daidzein nanosuspension combined with 5-fluorouracil induces apoptosis and alleviate inflammation in Caco-2 colorectal adenocarcinoma cells
Merve Becit-Kızılkaya, Şeyma Öncü, Serkan Şen, et al.
Food Bioscience (2024) Vol. 61, pp. 104659-104659
Closed Access | Times Cited: 3
The Mechanistic Roles of ncRNAs in Promoting and Supporting Chemoresistance of Colorectal Cancer
Isaac Micallef, Byron Baron
Non-Coding RNA (2021) Vol. 7, Iss. 2, pp. 24-24
Open Access | Times Cited: 23
Allelic Frequency of DPYD Genetic Variants in Patients With Cancer in Spain: The PhotoDPYD Study
Marta Miarons, Alba Manzaneque Gordón, Pau Riera, et al.
The Oncologist (2023) Vol. 28, Iss. 5, pp. e304-e308
Open Access | Times Cited: 9
Inhibition of NLRP3 inflammasome activation in myeloid-derived suppressor cells by andrographolide sulfonate contributes to 5-FU sensitization in mice
Lingyan Xu, Peifen Cai, Xiaofei Li, et al.
Toxicology and Applied Pharmacology (2021) Vol. 428, pp. 115672-115672
Closed Access | Times Cited: 18
Colon Cancer Pharmacogenetics: A Narrative Review
Álvaro Esteban Alfaro Alfaro, Brayan Murillo Castillo, Eugenia Cordero García, et al.
Pharmacy (2022) Vol. 10, Iss. 4, pp. 95-95
Open Access | Times Cited: 12
Sparassis latifolia and exercise training as complementary medicine mitigated the 5-fluorouracil potent side effects in mice with colorectal cancer: bioinformatics approaches, novel monitoring pathological metrics, screening signatures, and innovative management tactic
Navid Abedpoor, Farzaneh Taghian, Khosro Jalali Dehkordi, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Au-doped Fe3O4 nanoparticle as an effective nanocarrier for delivery of 5-fluorouracil anti-liver cancer drug
Xiaodong Sun, Guangjun Huang, Fei Shao, et al.
Inorganic Chemistry Communications (2024) Vol. 167, pp. 112685-112685
Closed Access | Times Cited: 2
An acid-activatable fluorouracil prodrug for colorectal cancer synergistic therapy
Xiaoqian Ma, Nuo Lin, Ke Hu, et al.
Acta Biomaterialia (2024) Vol. 185, pp. 350-360
Closed Access | Times Cited: 2
Chemotoxicity and Associated Risk Factors in Colorectal Cancer: A Systematic Review and Meta-Analysis
Claire J. Han, Ning Xia, Christin E. Burd, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2597-2597
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top